Drugdiscovery >> Drugs >> News
6470
Views
title
Bayer's riociguat approved in two pulmonary hypertension indications - drugdiscovery.com


FDA has backed approval of the drug for the treatment of both pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Read More >>


Tags: FDA, approval, Bayer, riociguat, indication, pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension - August 10, 2013
Related Articles
4492
Views
FDA approves Adempas for the treatment of two forms of pulmonary hypertension FDA approves Adempas for the treatment of two forms of pulmonary hypertension
Bayer HealthCare’s drug Adempas (riociguat) is approved by the FDA for the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) after surgical treatmen Read More >>

Tags: Adempas, riociguat, treatment, drug, pulmonary hypertension, pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension

5195
Views
Orphan drug designation for Bayer’s hypertension drug riociguat Orphan drug designation for Bayer’s hypertension drug riociguat
The FDA has granted two separate orphan drug designations for riociguat, Bayer’s investigational hypertension drug, for the treatment of pulmonary arterial hypertension and chronic thromboembolic pu Read More >>

Tags: riociguat, hypertension, drug, orphan drug designation, orphan, Bayer, pulmonary arterial hypertension, chronic thromboembolic pulmonary hypertension

5836
Views
Bayer's hypertension drug Adempas approved in Canada Bayer's hypertension drug Adempas approved in Canada
The Health Canada has approved the drug Adempas (riociguat) for the treatment of a severe, progressive and life-threatening condition of the heart and lungs, chronic thromboembolic pulmonary hypertens Read More >>

Tags: Adempas, riociguat, Bayer, hypertension drug, thromboembolic, pulmonary hypertension, Canada, approval

13253
Views
Bayer’s new hypertension drug to be approved by FDA Bayer’s new hypertension drug to be approved by FDA
The new drug worked well in clinical trials and is recommended for approval but at lower doses than those proposed by the company. Read More >>

Tags: Bayer, new drug, hypertension, pulmonary hypertension

5742
Views
A  high blood pressure drug approved for kids too A high blood pressure drug approved for kids too
FDA has approved Silvergate Pharmaceuticals’ drug Epaned (enalapril maleate powder for oral solution) for the treatment of hypertension in patients aged one month and older. Read More >>

Tags: Epaned, hypertension, high blood pressure, children, pediatric patients

14583
Views
How Drugs are Developed and Approved How Drugs are Developed and Approved
In the United States, all medications except natural remedies and supplements, must go through an approval process before they can be made available to people. The Food and Drug Administration (FDA) i Read More >>

Tags: FDA, CDER, drug safety

4749
Views
Taxol: indications, interactions, side effects and warnings Taxol: indications, interactions, side effects and warnings
Taxol (paclitaxel) is a mitotic inhibitor chemotherapy drug used to treat patients with lung, ovarian, breast, head and neck cancer, and advanced forms of Kaposi's sarcoma. Read More >>

Tags: Taxol, paclitaxel, mitotic inhibitor, chemotherapy, drug, side effects, warnings, indications

10294
Views
Another Sanofi MS drug approved in EU Another Sanofi MS drug approved in EU
After Aubagio, Lemtrada - another Sanofi’s drug for treatment of multiple sclerosis has been approved by the European Commission. Read More >>

Tags: multiple sclerosis, Europe, new drug, Aubagio, Lemtrada

6274
Views
Remicade Copies Approved in Europe Remicade Copies Approved in Europe
J&J’s Remicade, a drug for arthritis, will have cheaper versions made and sold by two other companies in Europe by 2014. Read More >>

Tags: Remicade, Arthritis, Celltrion, Hospira

11892
Views
New drug for treating myeloma approved in Europe New drug for treating myeloma approved in Europe
The European Commission has granted approval for Celgene’s drug pomalidomide for the treatment of relapsed and refractory multiple myeloma, in combination with dexamethasone. The marketing name of Read More >>

Tags: Celgene, pomalidomide, multiple myeloma,Imnovid,the European Commission approval

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013